BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 23382912)

  • 1. Relevance of TNBS-colitis in rats: a methodological study with endoscopic, histologic and Transcriptomic [corrected] characterization and correlation to IBD.
    Brenna Ø; Furnes MW; Drozdov I; van Beelen Granlund A; Flatberg A; Sandvik AK; Zwiggelaar RT; Mårvik R; Nordrum IS; Kidd M; Gustafsson BI
    PLoS One; 2013; 8(1):e54543. PubMed ID: 23382912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the usefulness of colonoscopy with mucosal biopsies in the follow-up of TNBS-induced colitis in rats.
    El-Salhy M; Wendelbo IH; Gundersen D; Hatlebakk JG; Hausken T
    Mol Med Rep; 2013 Aug; 8(2):446-50. PubMed ID: 23778962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of thalidomide on trinitrobenzene sulfonate-induced colitis in young rats and its mechanism.
    Xu J; Zheng C; Huang Y; Liang Y
    Chin Med J (Engl); 2014; 127(12):2368-75. PubMed ID: 24931258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of colonoscopy to follow the inflammatory time course of TNBS colitis in rats.
    Vermeulen W; De Man JG; Nullens S; Pelckmans PA; De Winter BY; Moreels TG
    Acta Gastroenterol Belg; 2011 Jun; 74(2):304-11. PubMed ID: 21861315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hUC-MSCs therapy for Crohn's disease: efficacy in TNBS-induced colitis in rats and pilot clinical study.
    Sun Q; Li S; Lin R; Zhao G; Lu J; Liu B; Hu M; Wang W; Yang X; Wei Y; Jia W; Hu Y; Zhang W; Zhu J; Cui D; Zhong L
    EBioMedicine; 2024 May; 103():105128. PubMed ID: 38653187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in enteroendocrine and immune cells following colitis induction by TNBS in rats.
    El-Salhy M; Hatlebakk JG
    Mol Med Rep; 2016 Dec; 14(6):4967-4974. PubMed ID: 27840918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astragaloside IV ameliorates 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis implicating regulation of energy metabolism.
    Jiang XG; Sun K; Liu YY; Yan L; Wang MX; Fan JY; Mu HN; Li C; Chen YY; Wang CS; Han JY
    Sci Rep; 2017 Feb; 7():41832. PubMed ID: 28150820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The guanylate cyclase-C signaling pathway is down-regulated in inflammatory bowel disease.
    Brenna Ø; Bruland T; Furnes MW; Granlund Av; Drozdov I; Emgård J; Brønstad G; Kidd M; Sandvik AK; Gustafsson BI
    Scand J Gastroenterol; 2015; 50(10):1241-52. PubMed ID: 25979109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome Based Profiling of the Immune Cell Gene Signature in Rat Experimental Colitis and Human IBD Tissue Samples.
    Boros É; Prontvai B; Kellermayer Z; Balogh P; Sarlós P; Vincze Á; Varga C; Maróti Z; Bálint B; Nagy I
    Biomolecules; 2020 Jun; 10(7):. PubMed ID: 32610492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of experimental mouse models of inflammatory bowel disease.
    Oh SY; Cho KA; Kang JL; Kim KH; Woo SY
    Int J Mol Med; 2014 Feb; 33(2):333-40. PubMed ID: 24285285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-inflammatory miR-223 mediates the cross-talk between the IL23 pathway and the intestinal barrier in inflammatory bowel disease.
    Wang H; Chao K; Ng SC; Bai AH; Yu Q; Yu J; Li M; Cui Y; Chen M; Hu JF; Zhang S
    Genome Biol; 2016 Mar; 17():58. PubMed ID: 27029486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of treatment with transglutaminase inhibitor cystamine on the severity of inflammation in a rat model of inflammatory bowel disease.
    Elli L; Ciulla MM; Busca G; Roncoroni L; Maioli C; Ferrero S; Bardella MT; Bonura A; Paliotti R; Terrani C; Braidotti P
    Lab Invest; 2011 Mar; 91(3):452-61. PubMed ID: 21042292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal PET/CT evaluation of TNBS-induced inflammatory bowel disease rat model.
    Seoane-Viaño I; Gómez-Lado N; Lázare-Iglesias H; Barreiro-de Acosta M; Silva-Rodríguez J; Luzardo-Álvarez A; Herranz M; Otero-Espinar F; Antúnez-López JR; Lamas MJ; Aguiar P; Fernández-Ferreiro A; Ruibal Á
    Int J Pharm; 2018 Oct; 549(1-2):335-342. PubMed ID: 30081226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal anti-inflammatory activity of hydroalcoholic extracts of Phlomis purpurea L. and Phlomis lychnitis L. in the trinitrobenzenesulphonic acid model of rat colitis.
    Algieri F; Zorrilla P; Rodriguez-Nogales A; Garrido-Mesa N; Bañuelos O; González-Tejero MR; Casares-Porcel M; Molero-Mesa J; Zarzuelo A; Utrilla MP; Rodriguez-Cabezas ME; Galvez J
    J Ethnopharmacol; 2013 Apr; 146(3):750-9. PubMed ID: 23395625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease.
    te Velde AA; de Kort F; Sterrenburg E; Pronk I; ten Kate FJ; Hommes DW; van Deventer SJ
    Inflamm Bowel Dis; 2007 Mar; 13(3):325-30. PubMed ID: 17206675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of humanin on experimental colitis induced by 2,4,6-trinitrobenzene sulphonic acid in rats.
    Gultekin FA; Emre AU; Celik SK; Barut F; Tali U; Sumer D; Turkcu UO
    Saudi J Gastroenterol; 2017; 23(2):105-111. PubMed ID: 28361841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular profiling of a rat model of colitis: validation of known inflammatory genes and identification of novel disease-associated targets.
    Rivera E; Flores I; Rivera E; Appleyard CB
    Inflamm Bowel Dis; 2006 Oct; 12(10):950-66. PubMed ID: 17012966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A low dose of fermented soy germ alleviates gut barrier injury, hyperalgesia and faecal protease activity in a rat model of inflammatory bowel disease.
    Moussa L; Bézirard V; Salvador-Cartier C; Bacquié V; Lencina C; Lévêque M; Braniste V; Ménard S; Théodorou V; Houdeau E
    PLoS One; 2012; 7(11):e49547. PubMed ID: 23166707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of AP‑1 and NF‑κB inhibitors on colonic endocrine cells in rats with TNBS‑induced colitis.
    El-Salhy M; Umezawa K
    Mol Med Rep; 2016 Aug; 14(2):1515-22. PubMed ID: 27357734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.